#127273
Re: Farmas USA
alerta posible chicharro / pero NK Cells
@igonber conoces esta? GTBP
Pasará estos días a cotizar del OTC al nasdaq via reverse merger , a 5.5$
GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced the pricing of an underwritten public offering of 4,300,000 Units, consisting of one share of its common stock and one warrant to purchase one share of its common stock, at a public offering price of $5.50 per Unit
https://www.gtbiopharma.com/product-pipeline/overview
@igonber conoces esta? GTBP
Pasará estos días a cotizar del OTC al nasdaq via reverse merger , a 5.5$
GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced the pricing of an underwritten public offering of 4,300,000 Units, consisting of one share of its common stock and one warrant to purchase one share of its common stock, at a public offering price of $5.50 per Unit
https://www.gtbiopharma.com/product-pipeline/overview